Skip to main content
Erschienen in: Rheumatology International 9/2009

01.06.2009 | Original Article

Mycobacterium tuberculosis infection precipitates SLE in patients from endemic areas

verfasst von: Kanjaksha Ghosh, Manisha Patwardhan, Vandana Pradhan

Erschienen in: Rheumatology International | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

In a cohort of 70 systemic lupus erythematosus (SLE) patients diagnosed over 2 years period, 14 patients were found to have confirmed antecedent tuberculosis (20.0%) which was 40 times higher (p < 0.001, 95%CI 36.2–48.6) than the prevalence of tuberculosis in the local population. Demonstration of anti-histone antibodies in similar proportion of SLE patients with and without antecedent anti-TB treatment and similar proportion of renal involvement (36 vs. 40%) between anti-TB drug exposed and non-exposed patients ruled out the drugs to be causative factors in precipitating SLE in these patients with antecedent history of tuberculosis. A cohort of 30 confirmed pulmonary tuberculosis patients were also studied in parallel to demonstrate high incidence of autoantibodies in these patients but no SLE. This study suggests a role of prior tuberculosis in precipitating SLE in genetically predisposed patients.
Literatur
1.
Zurück zum Zitat Erdozain JG, Ruiz-Irastroza G, Ebubride MV, Mantinez-Berrriot Xoa A (2006) Aguirrec, high risk of tuberculosis in systemic lupus erythematosus? Lupus 15:232–235. doi:10.1191/0961203306lu2289xx Erdozain JG, Ruiz-Irastroza G, Ebubride MV, Mantinez-Berrriot Xoa A (2006) Aguirrec, high risk of tuberculosis in systemic lupus erythematosus? Lupus 15:232–235. doi:10.​1191/​0961203306lu2289​xx
2.
Zurück zum Zitat Sayarlioglu M, Inanc M, Kamali S, Cefle A, Karamen O, Gul A et al (2004) Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localisation. Lupus 13:274–278. doi:10.1191/0961203303lu529xx PubMedCrossRef Sayarlioglu M, Inanc M, Kamali S, Cefle A, Karamen O, Gul A et al (2004) Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localisation. Lupus 13:274–278. doi:10.​1191/​0961203303lu529x​x PubMedCrossRef
3.
Zurück zum Zitat Balakrishnan C, Hangat G, Mittal G, Joshi VR (1998) Tuberculosis in patients with systemic lupus erythematosus. J Assoc Phys Ind 46:682–683 Balakrishnan C, Hangat G, Mittal G, Joshi VR (1998) Tuberculosis in patients with systemic lupus erythematosus. J Assoc Phys Ind 46:682–683
4.
Zurück zum Zitat Yun JE, Lee SW, Kim TH, Jun JB, Jung S, Bae SC, Kim TY, Yoo DH (2002) The incidence and clinical characteristics of tuberculosis infection among systemic lupus erythematosus and Rheumatoid arthritis patients in Korea. Clin Exp Rheumatol 20:127–132PubMed Yun JE, Lee SW, Kim TH, Jun JB, Jung S, Bae SC, Kim TY, Yoo DH (2002) The incidence and clinical characteristics of tuberculosis infection among systemic lupus erythematosus and Rheumatoid arthritis patients in Korea. Clin Exp Rheumatol 20:127–132PubMed
5.
Zurück zum Zitat Lamm DL, Blumenstein BA, Crowford ED, Montie JE, Scardino P, Grossman HB et al (1991) A randomized trial of intravesical doxorubicin and immunotherapy with Bacille Calmette-Guerin for transitional cell carcinoma of the bladder. N Engl J Med 352:1205–1209CrossRef Lamm DL, Blumenstein BA, Crowford ED, Montie JE, Scardino P, Grossman HB et al (1991) A randomized trial of intravesical doxorubicin and immunotherapy with Bacille Calmette-Guerin for transitional cell carcinoma of the bladder. N Engl J Med 352:1205–1209CrossRef
6.
Zurück zum Zitat Krone B, Kolmel KF, Henz BM, Wange JM (2005) Protection against melanoma by vaccination of Bacille Calmette guerin (BCG) and/or vaccinia: an epidemiology based hypothesis on the nature of melanoma risk factor and its immunological control. Eur J Cancer 41:104–117. doi:10.1016/j.ejca.2004.08.010 PubMedCrossRef Krone B, Kolmel KF, Henz BM, Wange JM (2005) Protection against melanoma by vaccination of Bacille Calmette guerin (BCG) and/or vaccinia: an epidemiology based hypothesis on the nature of melanoma risk factor and its immunological control. Eur J Cancer 41:104–117. doi:10.​1016/​j.​ejca.​2004.​08.​010 PubMedCrossRef
7.
Zurück zum Zitat Burling F, Ng J, Thein H, Ly J, Marshall MR, Gow P (2007) Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multiethnic New Zealand cohort. Lupus 16:830–837. doi:10.1177/0961203307080225 PubMedCrossRef Burling F, Ng J, Thein H, Ly J, Marshall MR, Gow P (2007) Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multiethnic New Zealand cohort. Lupus 16:830–837. doi:10.​1177/​0961203307080225​ PubMedCrossRef
9.
Zurück zum Zitat Holoshitz J, Hatitisk A, Cohen IR (1984) Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J Clin Invest 73:211–215. doi:10.1172/JCI111193 PubMedCrossRef Holoshitz J, Hatitisk A, Cohen IR (1984) Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J Clin Invest 73:211–215. doi:10.​1172/​JCI111193 PubMedCrossRef
10.
Zurück zum Zitat Van Eden U, Holoshitz J, Nevo Z, Frenkel A, Klugman A, Cohen IR (1985) Arthritis induced by a T lymphocyte clone that responds to mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci USA 82:5117–5120. doi:10.1073/pnas.82.15.5117 PubMedCrossRef Van Eden U, Holoshitz J, Nevo Z, Frenkel A, Klugman A, Cohen IR (1985) Arthritis induced by a T lymphocyte clone that responds to mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci USA 82:5117–5120. doi:10.​1073/​pnas.​82.​15.​5117 PubMedCrossRef
11.
12.
Zurück zum Zitat Pradhan VD, Badakere SS, Ghosh K, Pawar A (2004) Spectrum of anti-neutrophil cytoplasmic antibodies in patients with pulmonart tuberculosis overlaps with that of Wegener’s Granulomatous. Int J Med Sci 58:283–288 Pradhan VD, Badakere SS, Ghosh K, Pawar A (2004) Spectrum of anti-neutrophil cytoplasmic antibodies in patients with pulmonart tuberculosis overlaps with that of Wegener’s Granulomatous. Int J Med Sci 58:283–288
14.
Zurück zum Zitat Shoenfield Y, Schwatz RS (1984) Immunologic and genetic factors in autoimmune diseases. N Engl J Med 311:1019–1029 Shoenfield Y, Schwatz RS (1984) Immunologic and genetic factors in autoimmune diseases. N Engl J Med 311:1019–1029
15.
Zurück zum Zitat Shoenfoeld Y, Vilner Y, Coates ARM, Ranch J, Lavie G, Shaul D et al (1986) Monoclonal antituberculosis antibodies react with DNA and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol 66:255–261 Shoenfoeld Y, Vilner Y, Coates ARM, Ranch J, Lavie G, Shaul D et al (1986) Monoclonal antituberculosis antibodies react with DNA and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. Clin Exp Immunol 66:255–261
16.
Zurück zum Zitat Purice S, Mitu S, Popescu T, Guran M, Vintila M, Suta G (1982) The relationship between systemic lupus erythematosus and tuberculosis. Med Interne 20:191–196PubMed Purice S, Mitu S, Popescu T, Guran M, Vintila M, Suta G (1982) The relationship between systemic lupus erythematosus and tuberculosis. Med Interne 20:191–196PubMed
17.
Zurück zum Zitat Correa PA, Gomez LM, Cadena J, Anaya JM (2005) Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 32:219–225PubMed Correa PA, Gomez LM, Cadena J, Anaya JM (2005) Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol 32:219–225PubMed
18.
Zurück zum Zitat Sanger C, Busche A, Bentien G, Spallek R, Jonas F, Bohle A et al (2004) Immunodominant Pst S1 antigen of Mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer. BMC Cancer 4:86. doi:10.1186/1471-2407-4-86 PubMedCrossRef Sanger C, Busche A, Bentien G, Spallek R, Jonas F, Bohle A et al (2004) Immunodominant Pst S1 antigen of Mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer. BMC Cancer 4:86. doi:10.​1186/​1471-2407-4-86 PubMedCrossRef
Metadaten
Titel
Mycobacterium tuberculosis infection precipitates SLE in patients from endemic areas
verfasst von
Kanjaksha Ghosh
Manisha Patwardhan
Vandana Pradhan
Publikationsdatum
01.06.2009
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 9/2009
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-0903-x

Weitere Artikel der Ausgabe 9/2009

Rheumatology International 9/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.